{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:43:13Z","timestamp":1792176193326,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,2,28]],"date-time":"2015-02-28T00:00:00Z","timestamp":1425081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s15010-015-0748-z","type":"journal-article","created":{"date-parts":[[2015,2,27]],"date-time":"2015-02-27T09:53:54Z","timestamp":1425030834000},"page":"325-330","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prevalence of Brucella antibodies on a previously acute brucellosis infected population: sensitivity, specificity and predictive values of Rose Bengal and Wright standard tube agglutination tests"],"prefix":"10.1007","volume":"43","author":[{"given":"Panagiotis","family":"Andriopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Kalogerakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Rebelou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Paola Rojas","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Zyga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki","family":"Gennimata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tsironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,28]]},"reference":[{"key":"748_CR1","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.ijantimicag.2010.06.015","volume":"36","author":"J Solera","year":"2010","unstructured":"Solera J. Update on brucellosis: therapeutic challenges. Int J Antimicrob Agents. 2010;36:S18\u201320.","journal-title":"Int J Antimicrob Agents"},{"key":"748_CR2","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3201\/eid1108.041197","volume":"11","author":"P Yagupsky","year":"2005","unstructured":"Yagupsky P, Baron EJ. Laboratory exposures to brucellae and implications for bioterrorism. Emerg Infect Dis. 2005;11:1180\u20135.","journal-title":"Emerg Infect Dis"},{"key":"748_CR3","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1586\/eri.11.55","volume":"9","author":"S Al Dahouk","year":"2011","unstructured":"Al Dahouk S, Nockler K. Implications of laboratory diagnosis on brucellosis therapy. Expert Rev Anti Infect Ther. 2011;9:833\u201345.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"748_CR4","volume-title":"Fact sheet N173","author":"World Health Organization","year":"1997","unstructured":"World Health Organization. Fact sheet N173. Geneva: World Health Organization; 1997."},{"key":"748_CR5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1473-3099(07)70286-4","volume":"7","author":"MP Franco","year":"2007","unstructured":"Franco MP, Mulder M, Gilman RH, Smits HL. Human brucellosis. Lancet Infect Dis. 2007;7:775\u201386.","journal-title":"Lancet Infect Dis"},{"key":"748_CR6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1574891X11308010007","volume":"8","author":"A Ulu-Kilic","year":"2013","unstructured":"Ulu-Kilic A, Metan G, Alp E. Clinical presentations and diagnosis of brucellosis. Recent Pat Antiinfect Drug Discov. 2013;8:34\u201341.","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"748_CR7","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.ijantimicag.2010.06.014","volume":"36","author":"GF Araj","year":"2010","unstructured":"Araj GF. Update on laboratory diagnosis of human brucellosis. Int J Antimicrob Agents. 2010;36:S12\u20137.","journal-title":"Int J Antimicrob Agents"},{"key":"748_CR8","first-page":"66","volume-title":"Annual epidemiological report 2013. Reporting on 2011 surveillance data and 2012 epidemic intelligence data","author":"European Centre for Disease Prevention and Control","year":"2013","unstructured":"European Centre for Disease Prevention and Control. Annual epidemiological report 2013. Reporting on 2011 surveillance data and 2012 epidemic intelligence data. Stockholm: ECDC; 2013. p. 66\u20138."},{"key":"748_CR9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijid.2005.10.011","volume":"11","author":"P Andriopoulos","year":"2007","unstructured":"Andriopoulos P, Tsironi M, Deftereos S, Aessopos A, Assimakopoulos G. Acute brucellosis: presentation, diagnosis, and treatment of 144 cases. Int J Infect Dis. 2007;11:52\u20137.","journal-title":"Int J Infect Dis"},{"key":"748_CR10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7754\/Clin.Lab.2013.121120","volume":"60","author":"BG Mantur","year":"2014","unstructured":"Mantur BG, Amarnath SK, Patil GA, Desai AS. Clinical utility of a quantitative Rose Bengal slide agglutination test in the diagnosis of human brucellosis in an endemic region. Clin Lab. 2014;60:533\u201341.","journal-title":"Clin Lab"},{"key":"748_CR11","first-page":"1","volume-title":"Brucellosis in humans and animals","author":"World Health Organisation","year":"2006","unstructured":"World Health Organisation. Brucellosis in humans and animals. Geneva: World Health Organization; 2006. p. 1\u201341."},{"key":"748_CR12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0399-077X(02)00403-1","volume":"32","author":"B Aygen","year":"2002","unstructured":"Aygen B, Doganay M, S\u00fcmerkan B, Yildiz O, Kayaba\u015fa U. Clinical manifestations, complications and treatment of brucellosis: a retrospective evaluation of 480 patients. Med Mal Infect. 2002;32:485\u201393.","journal-title":"Med Mal Infect"},{"key":"748_CR13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s100670050087","volume":"18","author":"Y Tasova","year":"1999","unstructured":"Tasova Y, Saltoglu N, Sahin G, Aksu HS. Osteoarthricular involvement of brucellosis in Turkey. Clin Rheumatol. 1999;18:214\u20139.","journal-title":"Clin Rheumatol"},{"key":"748_CR14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2169\/internalmedicine.50.4700","volume":"50","author":"H Turan","year":"2011","unstructured":"Turan H, Serefhanoglu K, Karadeli E, Togan T, Arslan H. Osteoarticular involvement among 202 brucellosis cases identified in Central Anatolia region of Turkey. Intern Med. 2011;50:421\u20138.","journal-title":"Intern Med"},{"key":"748_CR15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/1319-3767.33333","volume":"11","author":"S Aziz","year":"2005","unstructured":"Aziz S, Al-Anazi AR, Al-Aska AI. A review of gastrointestinal manifestations of Brucellosis. Saudi J Gastroenterol. 2005;11:20\u20137.","journal-title":"Saudi J Gastroenterol"},{"key":"748_CR16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/0036554021000027025","volume":"35","author":"P Andriopoulos","year":"2003","unstructured":"Andriopoulos P, Tsironi M, Asimakopoulos G. Acute abdomen due to Brucella melitensis. Scand J Infect Dis. 2003;35:204\u20135.","journal-title":"Scand J Infect Dis"},{"key":"748_CR17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijid.2005.02.006","volume":"10","author":"E Akinci","year":"2006","unstructured":"Akinci E, Bodur H, Cevik MA, et al. A complication of brucellosis: epididymoorchitis. Int J Infect Dis. 2006;10:171\u20137.","journal-title":"Int J Infect Dis"},{"key":"748_CR18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1201-9712(02)90166-9","volume":"6","author":"AG Papatsoris","year":"2002","unstructured":"Papatsoris AG, Mpadra FA, Karamouzis MV, Frangides CY. Endemic brucellar epididymo-orchitis: a 10-year experience. Int J Infect Dis. 2002;6:309\u201313.","journal-title":"Int J Infect Dis"},{"key":"748_CR19","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2169\/internalmedicine.53.0936","volume":"53","author":"AE Eskazan","year":"2014","unstructured":"Eskazan AE, Dal MS, Kaya S, Dal T, Ayyildiz O, Soysal T. Two cases of autoimmune hemolytic anemia secondary to brucellosis: a review of hemolytic disorders in patients with brucellosis. Intern Med. 2014;53:1153\u20138.","journal-title":"Intern Med"},{"key":"748_CR20","doi-asserted-by":"crossref","first-page":"e2010031","DOI":"10.4084\/mjhid.2010.031","volume":"2","author":"AA Kuperman","year":"2010","unstructured":"Kuperman AA, Baidousi A, Nasser M, Braester A, Nassar F. Microangiopathic anemia of acute brucellosis\u2014is it a True TTP? Mediterr J Hematol Infect Dis. 2010;2:e2010031.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"748_CR21","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1086\/318129","volume":"31","author":"EJ Young","year":"2000","unstructured":"Young EJ, Tarry A, Genta RM, Ayden N, Gotuzzo E. Thrombocytopenic purpura associated with brucellosis: report of 2 cases and literature review. Clin Infect Dis. 2000;31:904\u20139.","journal-title":"Clin Infect Dis"},{"key":"748_CR22","first-page":"255","volume":"48","author":"J Solera","year":"2000","unstructured":"Solera J. Treatment of human brucellosis. J Med Liban. 2000;48:255\u201363.","journal-title":"J Med Liban"},{"key":"748_CR23","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1086\/501359","volume":"42","author":"MR HasanjaniRoushan","year":"2006","unstructured":"HasanjaniRoushan MR, Mohraz M, Hajiahmadi M, Ramzani A, Valayati AA. Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans. Clin Infect Dis. 2006;42:1075\u201380.","journal-title":"Clin Infect Dis"},{"key":"748_CR24","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/bmj.39497.500903.25","volume":"336","author":"K Skalsky","year":"2008","unstructured":"Skalsky K, Yahav D, Bishara J, Pitlik S, Leibovici L, Paul M. Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials. BMJ. 2008;336:701\u20134.","journal-title":"BMJ"},{"key":"748_CR25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1258\/td.2009.090030","volume":"39","author":"F Keramat","year":"2009","unstructured":"Keramat F, Ranjbar M, Mamani M, Hashemi SH, Zeraati F. A comparative trial of three therapeutic regimens: ciprofloxacin\u2013rifampin, ciprofloxacin\u2013doxycycline and doxycycline\u2013rifampin in the treatment of brucellosis. Trop Dr. 2009;39:207\u201310.","journal-title":"Trop Dr"},{"key":"748_CR26","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1016\/j.ijid.2011.12.003","volume":"16","author":"SH Hashemi","year":"2012","unstructured":"Hashemi SH, Gachkar L, Keramat F, et al. Comparison of doxycycline\u2013streptomycin, doxycycline\u2013rifampin, and ofloxacin\u2013rifampin in the treatment of brucellosis: a randomized clinical trial. Int J Infect Dis. 2012;16:e247\u201351.","journal-title":"Int J Infect Dis"},{"key":"748_CR27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1258\/td.2011.110284","volume":"42","author":"B Mile","year":"2012","unstructured":"Mile B, Valerija K, Krsto G, Ivan V, Ilir D, Nikola L. Doxycycline\u2013rifampin versus doxycycline\u2013rifampin\u2013gentamicin in treatment of human brucellosis. Trop Dr. 2012;42:13\u20137.","journal-title":"Trop Dr"},{"key":"748_CR28","first-page":"636","volume":"4","author":"SM Alavi","year":"2013","unstructured":"Alavi SM, Alavi L. Treatment of brucellosis: a systematic review of studies in recent twenty years. Casp J Intern Med. 2013;4:636\u201341.","journal-title":"Casp J Intern Med"},{"key":"748_CR29","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/clinids\/20.5.1241","volume":"20","author":"J Ariza","year":"1995","unstructured":"Ariza J, Corredoira J, Pallares R, et al. Characteristics of and risk factors for relapse of brucellosis in humans. Clin Infect Dis. 1995;20:1241\u20139.","journal-title":"Clin Infect Dis"},{"key":"748_CR30","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1128\/JCM.40.6.2313.2002","volume":"40","author":"M Almuneef","year":"2002","unstructured":"Almuneef M, Memish ZA. Persistence of Brucella antibodies after successful treatment of acute brucellosis in an area of endemicity. J Clin Microbiol. 2002;40:2313.","journal-title":"J Clin Microbiol"},{"key":"748_CR31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0732-8893(03)00081-6","volume":"46","author":"A Mert","year":"2003","unstructured":"Mert A, Ozaras R, Tabak F, et al. The sensitivity and specificity of Brucella agglutination tests. Diagn Microbiol Infect Dis. 2003;46:241\u20133.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"748_CR32","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jinf.2005.12.022","volume":"53","author":"S Kose","year":"2006","unstructured":"Kose S, Smits HL, Abdoel TH, Ozbel Y. Prevalence of Brucella antibodies in rural and suburban communities in three provinces of Turkey: need for improved diagnosis and prevention. J Infect. 2006;53:308\u201314.","journal-title":"J Infect"},{"key":"748_CR33","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1089\/fpd.2012.1360","volume":"10","author":"S Ali","year":"2013","unstructured":"Ali S, Ali Q, Neubauer H, et al. Seroprevalence and risk factors associated with brucellosis as a professional hazard in Pakistan. Foodborne Pathog Dis. 2013;10:500\u20135.","journal-title":"Foodborne Pathog Dis"},{"key":"748_CR34","first-page":"13","volume":"23","author":"AMU Din","year":"2013","unstructured":"Din AMU, Khan SA, Ahmad I, Rind R, Husain T, Shahid M, Ahmeddin S. A study on the seroprevalence of brucellosis in human and goat populations of district Bhimber, Azad Jammu and Kashmir. J Anim Plant Sci. 2013;23:13\u20138.","journal-title":"J Anim Plant Sci"},{"key":"748_CR35","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/ije\/25.2.450","volume":"25","author":"MN Abo-Shehada","year":"1996","unstructured":"Abo-Shehada MN, Odeh JS, Abu-Essud M, Abuharfeil N. Seroprevalence of brucellosis among high risk people in northern Jordan. Int J Epidemiol. 1996;25:450\u20134.","journal-title":"Int J Epidemiol"},{"key":"748_CR36","doi-asserted-by":"crossref","first-page":"19625","DOI":"10.2807\/ese.15.30.19625-en","volume":"15","author":"MO Ahmed","year":"2010","unstructured":"Ahmed MO, Elmeshri SE, Abuzweda AR, et al. Seroprevalence of brucellosis in animals and human populations in the western mountains region in Libya, December 2006\u2013January 2008. Euro Surveill. 2010;15:19625\u20138.","journal-title":"Euro Surveill"},{"key":"748_CR37","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jinf.2008.08.005","volume":"57","author":"M Mantecon de","year":"2008","unstructured":"de Mantecon M, Los GutierrezMP, de Zarzosa M, Los P, et al. Influence of brucellosis history on serological diagnosis and evolution of patients with acute brucellosis. J Infect. 2008;57:397\u2013403.","journal-title":"J Infect"},{"key":"748_CR38","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1016\/j.ijid.2009.05.008","volume":"14","author":"MR Roushan","year":"2010","unstructured":"Roushan MR, Amiri MJ, Laly A, Mostafazadeh A, Bijani A. Follow-up standard agglutination and 2-mercaptoethanol tests in 175 clinically cured cases of human brucellosis. Int J Infect Dis. 2010;14:e250\u20133.","journal-title":"Int J Infect Dis"},{"key":"748_CR39","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cimid.2009.06.001","volume":"33","author":"M Bosilkovski","year":"2010","unstructured":"Bosilkovski M, Katerina S, Zaklina S, Ivan V. The role of Brucellacapt test for follow-up patients with brucellosis. Comp Immunol Microbiol Infect Dis. 2010;33:435\u201342.","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"748_CR40","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1128\/CVI.00424-07","volume":"15","author":"MC Gomez","year":"2008","unstructured":"Gomez MC, Nieto JA, Rosa C, et al. Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic. Clin Vaccine Immunol. 2008;15:1031\u20133.","journal-title":"Clin Vaccine Immunol"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-015-0748-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-015-0748-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-015-0748-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T23:54:23Z","timestamp":1651362863000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-015-0748-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,28]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["748"],"URL":"https:\/\/doi.org\/10.1007\/s15010-015-0748-z","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,28]]}}}